176 related articles for article (PubMed ID: 31879266)
1. Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State.
Gray BP; Requena MD; Nichols MD; Sullenger BA
Cell Chem Biol; 2020 Feb; 27(2):232-244.e7. PubMed ID: 31879266
[TBL] [Abstract][Full Text] [Related]
2. Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells.
Requena MD; Yan A; Llanga T; Sullenger BA
Nucleic Acid Ther; 2024 Feb; 34(1):12-17. PubMed ID: 38285522
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of sorting of fluorescently and magnetically labelled dental pulp stem cells].
Kerényi F; Tarapcsák S; Hrubi E; Baráthne SÁ; Hegedüs V; Balogh S; Bágyi K; Varga G; Hegedüs C
Fogorv Sz; 2016 Mar; 109(1):29-33. PubMed ID: 27188159
[TBL] [Abstract][Full Text] [Related]
4. Pyrene-Modified DNA Aptamers with High Affinity to Wild-Type EGFR and EGFRvIII.
Zavyalova E; Turashev A; Novoseltseva A; Legatova V; Antipova O; Savchenko E; Balk S; Golovin A; Pavlova G; Kopylov A
Nucleic Acid Ther; 2020 Jun; 30(3):175-187. PubMed ID: 31990606
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell proliferation by an anti-EGFR aptamer.
Li N; Nguyen HH; Byrom M; Ellington AD
PLoS One; 2011; 6(6):e20299. PubMed ID: 21687663
[TBL] [Abstract][Full Text] [Related]
6. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
[TBL] [Abstract][Full Text] [Related]
7. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS).
Fong CY; Peh GS; Gauthaman K; Bongso A
Stem Cell Rev Rep; 2009 Mar; 5(1):72-80. PubMed ID: 19184635
[TBL] [Abstract][Full Text] [Related]
8. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
9. Rapid Selection of RNA Aptamers that Activate Fluorescence of Small Molecules.
Filonov GS
Methods Mol Biol; 2017; 1575():273-289. PubMed ID: 28255887
[TBL] [Abstract][Full Text] [Related]
10. Selection of DNA aptamers against epidermal growth factor receptor with high affinity and specificity.
Wang DL; Song YL; Zhu Z; Li XL; Zou Y; Yang HT; Wang JJ; Yao PS; Pan RJ; Yang CJ; Kang DZ
Biochem Biophys Res Commun; 2014 Oct; 453(4):681-5. PubMed ID: 25242523
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells.
Herr JK; Smith JE; Medley CD; Shangguan D; Tan W
Anal Chem; 2006 May; 78(9):2918-24. PubMed ID: 16642976
[TBL] [Abstract][Full Text] [Related]
12. Rapid Complexation of Aptamers by Their Specific Antidotes.
Stoll H; Steinle H; Wilhelm N; Hann L; Kunnakattu SJ; Narita M; Schlensak C; Wendel HP; Avci-Adali M
Molecules; 2017 Jun; 22(6):. PubMed ID: 28594360
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-facilitated biomarker discovery (AptaBiD).
Berezovski MV; Lechmann M; Musheev MU; Mak TW; Krylov SN
J Am Chem Soc; 2008 Jul; 130(28):9137-43. PubMed ID: 18558676
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of EGFR expression using an
Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577
[TBL] [Abstract][Full Text] [Related]
16. Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay.
Kim K; Lee S; Ryu S; Han D
Biochem Biophys Res Commun; 2014 May; 448(1):114-9. PubMed ID: 24768638
[TBL] [Abstract][Full Text] [Related]
17. Directed evolution of gold nanoparticle delivery to cells.
Li N; Larson T; Nguyen HH; Sokolov KV; Ellington AD
Chem Commun (Camb); 2010 Jan; 46(3):392-4. PubMed ID: 20066302
[TBL] [Abstract][Full Text] [Related]
18. Protocol for purification of cells in their native state using reversible aptamer-antidote pairs.
Requena MD; Gray BP; Sullenger BA
STAR Protoc; 2023 Sep; 4(3):102348. PubMed ID: 37314924
[TBL] [Abstract][Full Text] [Related]
19. Selection of aptamers against Lactoferrin based on silver enhanced and fluorescence-activated cell sorting.
Yu F; Li H; Sun W; Zhao Y; Xu D; He F
Talanta; 2019 Feb; 193():110-117. PubMed ID: 30368278
[TBL] [Abstract][Full Text] [Related]
20. Selection of Intracellularly Functional RNA Mimics of Green Fluorescent Protein Using Fluorescence-Activated Cell Sorting.
Zou J; Huang X; Wu L; Chen G; Dong J; Cui X; Tang Z
J Mol Evol; 2015 Dec; 81(5-6):172-8. PubMed ID: 26573804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]